Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis

Elisa Petruccioli, Thomas J. Scriba, Linda Petrone, Mark Hatherill, Daniela M. Cirillo, Simone A. Joosten, Tom H. Ottenhoff, Claudia M. Denkinger, Delia Goletti

Source: Eur Respir J 2016; 48: 1751-1763
Journal Issue: December
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Elisa Petruccioli, Thomas J. Scriba, Linda Petrone, Mark Hatherill, Daniela M. Cirillo, Simone A. Joosten, Tom H. Ottenhoff, Claudia M. Denkinger, Delia Goletti. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur Respir J 2016; 48: 1751-1763

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


Predictive factors of relapse in pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012

Who is at risk for active tuberculosis?
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003

Predictive factors for risk of decease in tuberculosis (TB)-HIV co-infected patients
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010


Characteristics and risk factors for missed pulmonary tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease
Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017
Year: 2018



HIV and multidrug-resistant tuberculosis: overlapping risk factors
Source: Eur Respir J 2015; 45: 567-569
Year: 2015


Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013



Effect of the risk factors on the characteristics of the disease in patients with pulmonary tuberculosis
Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups
Year: 2008

Site of active tuberculosis disease predicts survival in HIV-associated tuberculosis
Source: Annual Congress 2010 - Tuberculosis and HIV coinfection
Year: 2010



Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012


Who are at risk for tuberculosis recurrence?
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011

Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


A prediction rule to stratify mortality risk of patients with pulmonary tuberculosis
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016


Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016



Progression to tuberculosis disease increases with multiple exposures
Source: Eur Respir J 2016; 48: 1682-1689
Year: 2016



Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019
Year: 2020



Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016